BackPortola Pharmaceuticals Overview

Portola Pharmaceuticals Research & Development

Research & Development expenses for PTLA.

Quarterly R&D Expenses

$26.09M
↓ 26.68% YoY

As of Mar 31, 2020

Annual R&D Expenses (TTM)

$115.13M
↓ 39.95% YoY

Trailing 12 months ending Mar 31, 2020

Average R&D Expenses (Comparison Companies)

Research & Development History

Research & Development Comparison

Annual Research & Development Growth Rate (%)

Annual Research & Development Growth (Absolute)

Jump to metric
Total RevenueCost of RevenueGross ProfitResearch & DevelopmentSelling, General & AdminOperating IncomeOther Income Expense NetEBITIncome TaxNet IncomeProfit Margin